Company Analysis
Sign in

Replimune Group, Inc. (REPL)

Nasdaq: REPL · Biological Products, (No Diagnostic Substances) · filing with the SEC since 2018
Full chart Alerts Compare
Grade5.0
◀ Past 5.6● Present 4.3▶ Future 5.3
7 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in March.
Income statement, by fiscal year, newest first
Fiscal yearFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2019FY 2019FY 2018FY 2017
Period endingMar 31, 2026Mar 31, 2025Mar 31, 2024Mar 31, 2023Mar 31, 2022Mar 31, 2021Mar 31, 2020Mar 31, 2019Mar 31, 2018Mar 31, 2017
Report filedJun 29, 2026May 22, 2025May 16, 2024May 18, 2023May 19, 2022May 20, 2021Jun 3, 2020Jun 28, 2019··
Research and development221,184189,447174,963126,52779,54556,75438,76122,17313,5166,936
Selling, general and administrative98,73572,180········
General and administrative·72,18059,81050,55338,76923,20117,4378,7735,7132,711
Total operating expenses319,919261,627234,773177,080118,31479,95556,19830,94619,2299,647
Operating income-319,919-261,627-234,773-177,080-118,314-79,955-56,198-30,946-19,229-9,647
Interest expense6,7965,7754,4971,9630818734···
Interest and investment income13,62521,12023,35610,0063909162,4242,58528825
Other income (expense), net-942-202771-5,676-1,059-665-16451-2,056626
Total non-operating income (expense)5,42814,79819,3873,084278-9153,573112-4731,943
Income before income taxes-314,491-246,829-215,386-173,996-118,036-80,870-52,625-30,834-19,702-7,704
Income tax expense-551468408288000000
Income from continuing operations-314,491-246,829-215,386-173,996-118,036-80,870····
Net income including non-controlling interests-313,940-247,297-215,794-174,284-118,036-80,870-52,625-30,834r-19,702r7,704
Net income-313,940-247,297-215,794-174,284-118,036-80,870-52,625-30,834-19,702-7,704
Net income to common shareholders-313,940-247,297-215,794-174,284-118,036-80,870-52,625-30,834-19,702-7,704
Earnings per share, basic-3.38-3.07-3.24-2.99-2.26-1.75····
Earnings per share, diluted-3.38-3.07-3.24-2.99-2.26-1.75····
Earnings per share, basic and diluted·····-1.75-1.54-1.33-3.96-1.55
Weighted average shares, basic92,803,71180,564,14766,569,89458,213,01052,212,26946,248,969····
Weighted average shares, diluted92,803,71180,564,14766,569,89458,213,01052,212,26946,248,969····
Weighted average shares, basic and diluted·····46,248,96934,261,54823,198,4004,978,5394,973,439
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpenseDebt
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterestAndDividend
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Income from continuing operations profit from the businesses it keepsus-gaap:IncomeLossFromContinuingOperations
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton REPL · research, not advice